Sign in to view content

Amine Oxidase Copper-Containing 3 Inhibitor (BI 1467335) in Non-Proliferative Diabetic Retinopathy: Double-Masked, Randomized, Phase IIa Study (ROBIN)

Quan Dong Nguyen, MD, MSc, FARVO, FASRS

Video
Published 2021

Related

Diabetic Retinal Telescreening Program in a High-Risk Population Highlights Significant Rates of Retinal Pathology
Matthew P. Ohr, MD
Annual Meeting Talks
2020
E27- DRCR Protocol V Results- Anti-VEGF vs Focal Laser vs Observation for DME in Eyes with Very Good Vision- Dr. Jennifer Sun
Keyvan Koushan, MD, FRCSC
Member Podcasts
Improvement of Worsening in Diabetic Retinopathy Through 2 Years in a Randomized Trial
Susan B. Bressler, MD, FASRS
Updates from the Field
2017

Category: Diabetic Retinopathy

See more